Last reviewed · How we verify
NCT04834245
Evaluation of Diabetic Foot Wound Healing Using Hydrogel/Nano Silver-based Dressing vs. Traditional Dressing
NA trial testing Hydrogel/nano silver-based dressing in Diabetes Mellitus in 30 participants. Completed in 30 December 2019.
3 April 2019
Quick facts
| Lead sponsor | Magda Bayoumi |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 30 |
| Start date | 3 January 2019 |
| Primary completion | 3 April 2019 |
| Estimated completion | 30 December 2019 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Hydrogel/nano silver-based dressing
Conditions studied
- Diabetes Mellitus — all drugs for Diabetes Mellitus →
Sponsor
Magda Bayoumi
Who can join
Adults 35 to 55, any sex, with Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Background: The wound dressings perform a crucial role in the cutaneous wounds' management due to their ability to protect wounds and promote dermal and epidermal tissue regeneration. Objective: the aim of the present study to evaluate the effectiveness of using hydrogel/nano silver-based dressing vs. traditional dressing on diabetic foot wound healing. Approach: Sixty patients with type-2 diabetes hospitalized for diabetic foot wound treatment were recruited from selected Surgical departments at Kasr Al-Aini university hospital.
Publications & conference data
8 peer-reviewed publications reference this trial (live from Europe PMC):
-
Research advances in smart responsive-hydrogel dressings with potential clinical diabetic wound healing properties.
Chen Y, Wang X, Tao S, Wang Q, et al · · 2023 · cited 160× · PMID 37608335 · DOI 10.1186/s40779-023-00473-9 -
Current Overview of Metal Nanoparticles' Synthesis, Characterization, and Biomedical Applications, with a Focus on Silver and Gold Nanoparticles.
Burlec AF, Corciova A, Boev M, Batir-Marin D, et al · · 2023 · cited 93× · PMID 37895881 · DOI 10.3390/ph16101410 -
Nanocomposite hydrogels for biomedical applications.
Huang S, Hong X, Zhao M, Liu N, et al · · 2022 · cited 79× · PMID 36176618 · DOI 10.1002/btm2.10315 -
Biomedical Applications of Plant Extract-Synthesized Silver Nanoparticles.
Simon S, Sibuyi NRS, Fadaka AO, Meyer S, et al · · 2022 · cited 46× · PMID 36359308 · DOI 10.3390/biomedicines10112792 -
Plant Extract-Synthesized Silver Nanoparticles for Application in Dental Therapy.
Ahmed O, Sibuyi NRS, Fadaka AO, Madiehe MA, et al · · 2022 · cited 41× · PMID 35214112 · DOI 10.3390/pharmaceutics14020380 -
Recent Advances in Silver Nanoparticles Containing Nanofibers for Chronic Wound Management.
Sabarees G, Velmurugan V, Tamilarasi GP, Alagarsamy V, et al · · 2022 · cited 32× · PMID 36235942 · DOI 10.3390/polym14193994 -
Nanobiotechnology: Applications in Chronic Wound Healing.
Jiang T, Li Q, Qiu J, Chen J, et al · · 2022 · cited 32× · PMID 35898438 · DOI 10.2147/ijn.s372211 -
Functional Thermoresponsive Hydrogel Molecule to Material Design for Biomedical Applications.
Pardeshi S, Damiri F, Zehravi M, Joshi R, et al · · 2022 · cited 29× · PMID 35956641 · DOI 10.3390/polym14153126
Verify or expand the search:
- PubMed search for NCT04834245
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Diabetes Mellitus
Currently open trials in the same condition.
- NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
- NCT07392437 — Prevalence of Diabetes-related Distress Among Patients Living With Type 2 Diabetes in a University Hospital Center and I · NA · recruiting
- NCT07448805 — Accuracy and Safety of the Syai Tag System for Continuous Glucose Monitoring in Intensive Internal Care Unit · NA · recruiting
- NCT07425275 — Integrated Oral Care Intervention for Xerostomia in Diabetes Patients · NA · recruiting
- NCT06918977 — Improving Glycemic Control With Telemedicine and Smart Insulin Pens · NA · recruiting
Other Magda Bayoumi trials
Trials by the same sponsor.
- NCT04843592 — SOKARY Mobile Application With Type II Diabetes · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04834245 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Magda Bayoumi
- Last refreshed: 8 April 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04834245.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing